Benzyl benzoate

Generic Medicine Info
Indications and Dosage
Adult: As 25% emulsion: Apply over the whole body. If the application is thorough, one treatment may suffice, although a second application within 5 days may be necessary to lessen the possibility of treatment failure. Alternatively, 3 applications at 12-hour intervals may be made, followed by bathing 12 hours after the last application.

Adult: As 25% emulsion: Apply all over the affected area, then wash thoroughly after 24 hours.
Special Precautions
Avoid contact with eyes and mucous membranes. Do not use on broken or secondarily infected skin. Pregnancy and lactation.
Adverse Reactions
Eye disorders: Eye irritation.
Immune system disorders: Hypersensitivity reactions.
Skin and subcutaneous tissue disorders: Skin and mucous membranes (e.g. nostrils, mouth, lips, ears and genital area) irritation.
Mechanism of Action: Benzyl benzoate, an acaricide that is used in the treatment of scabies and pediculosis.
Chemical Structure

Chemical Structure Image
Benzyl benzoate

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 2345, Benzyl benzoate. Accessed Aug. 25, 2020.

Store below 25°C.
MIMS Class
Topical Antifungals & Antiparasites
ATC Classification
P03AX01 - benzyl benzoate ; Belongs to the class of other ectoparasiticides including scabicides.
Anon. Benzyl Benzoate. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. Accessed 18/08/2020.

Buckingham R (ed). Benzyl Benzoate. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. Accessed 20/07/2020.

Emulsion Benzyl Benzoate (Idaman Pharma Manufacturing Sdn Bhd). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. Accessed 20/07/2020.

Joint Formulary Committee. Benzyl Benzoate. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. Accessed 20/07/2020.

Scabicide Emulsion GPO (GPO). MIMS Thailand. Accessed 20/07/2020.

Disclaimer: This information is independently developed by MIMS based on Benzyl benzoate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in